Parkside Financial Bank & Trust’s Vaxcyte PCVX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.28K	Buy	108 +3	+3%	+$163	﹤0.01%	1818
2026 Q1	$6.1K	Hold	105	–	–	﹤0.01%	1757
2025 Q4	$4.84K	Buy	105 +14	+15%	+$626	﹤0.01%	1811
2025 Q3	$3.28K	Buy	91 +20	+28%	+$663	﹤0.01%	1858
2025 Q2	$2.31K	Buy	71 +66	+1,320%	+$2.16K	﹤0.01%	1955
2025 Q1	$189	Buy	+5	New	+$400	﹤0.01%	2684

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Parkside Financial Bank & Trust's PCVX Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Vaxcyte (PCVX) stake by 2.9% in Q2 2026, buying an estimated $163 and bringing the position to 108 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

Parkside Financial Bank & Trust first reported a position in PCVX in Q1 2025 and has held it in 6 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Parkside Financial Bank & Trust held 108 shares of Vaxcyte worth $6.28K as of Q2 2026.
Parkside Financial Bank & Trust bought 3 Vaxcyte shares in Q2 2026, an estimated $163.
Vaxcyte made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1818 holding.
Parkside Financial Bank & Trust first reported a position in Vaxcyte in Q1 2025 and has held it in 6 quarters since.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.